文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

验证已发表模型以减轻早产儿视网膜病变筛查负担

Validation of a Published Model to Reduce Burden of Retinopathy of Prematurity Screening.
PubMed 文献 · Am J Ophthalmol · 2023-09-09

该回顾性队列研究在美国中南部6个医疗中心纳入6729例接受早产儿视网膜病变(ROP)筛查的婴儿,其中298例(4.43%)接受治疗。结果复现了原E-ROP研究的发现:出生体重>750 g且胎龄>27周的婴儿若在37周胎龄时无ROP,则未发生需治疗的ROP,支持对符合这些标准的患者在此时间点终止检查。

要点

  • 出生体重>750 g且胎龄>27周的婴儿若37周时无ROP,未发生需治疗ROP。
  • 6729例筛查婴儿中298例(4.43%)接受治疗,仅1例符合上述标准且ROP在37周后首次检查即发现。
  • 结果支持对符合该标准的婴儿在37周终止筛查。

核心结论

  • 在样本量为原研究5倍的队列中复现了原E-ROP研究结果:出生体重>750 g且胎龄>27周的婴儿若37周时无ROP,未发生需治疗的ROP,支持对符合这些标准的患者在此时间点终止检查。

研究设计与样本

  • 回顾性队列研究,审查2004年2月至2022年4月在美国中南部6个医疗中心因ROP接受治疗的每一例婴儿的病历。

主要发现

  • 6729例筛查婴儿中298例(4.43%)接受治疗。
  • 10例需治疗婴儿在37周胎龄后首次出现ROP证据;其中仅1例出生体重>750 g且胎龄>27周,该患儿发生2区3期伴预附加病变,因偏远医院就医不便而接受治疗,但ROP在37周后首次检查即被检出,因此该婴儿本会被识别需继续随访。

关键数值与推荐

  • 出生体重>750 g且胎龄>27周的婴儿若37周胎龄时无ROP,未发生需治疗的ROP。

临床怎么用

  • 原文结论支持对出生体重>750 g且胎龄>27周、37周时无ROP的婴儿在此时间点终止筛查检查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The E-ROP study evaluated 1257 patients screened for retinopathy of prematurity (ROP), and found that no infant born at or after 27 weeks' gestational age and having a birthweight over 750 g developed treatable disease if they had no ROP at 37 weeks' gestational age. The study investigators suggested that there is little value in continued screening of infants meeting these criteria who have no ROP at 37 weeks. We attempted to replicate these published data in a larger multi-center cohort to validate or refute this hypothesis. DESIGN: Retrospective cohort study. METHODS: We conducted a chart review of every infant treated for ROP from February 2004 through April 2022 at 6 medical centers located in the mid-southern region of the United States. We evaluated gestational age, birthweight, and presence or absence of ROP at 37 weeks' gestational age to determine whether any treated infants would have been "missed" using these screening criteria. RESULTS: Of 6729 infants screened, 298 (4.43%) received treatment. Ten infants who required treatment developed first evidence of ROP after 37 weeks' gestational age. However, only 1 infant was >750 g birthweight and >27 weeks' gestational age. This patient developed zone 2, stage 3 with pre-plus disease and was treated because of limited access to care at a remote hospital; however, ROP was detected at the first examination after 37 weeks, so this infant would have been identified for continued follow-up. CONCLUSION: Our results, in a cohort 5 times that of the original study, replicated that infants >750 g birthweight and >27 weeks' gestational age did not develop treatable ROP if they had no ROP at 37 weeks, supporting the termination of examination at that time in patients meeting these criteria.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Pruett J, Ruland K, Donahue S, et al. Validation of a Published Model to Reduce Burden of Retinopathy of Prematurity Screening. Am J Ophthalmol. 2023. PMID: 37690501. doi:10.1016/j.ajo.2023.09.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。